challenges successes developing new therapies hepatitis c 
hepatitis c virus hcv will continue serious global health threat many years come chronic nature infection high prevalence significant morbidity resulting disease recently small number molecules produced encouraging results proof-of-concept clinical trials time preclinical evidence accumulating development resistance will eventually limit efficacy new drugs thus combinations multiple agents will required treat chronic hcv infection 
